Hey everyone! We’re Juliana and Robert, co-founders of Parallel Bio. We're improving drug discovery by replacing animal models, in the hope of making cures for humans, not mice. The biggest reason why 92% of new drugs fail is that drugs are currently discovered in mice, which are not realistic models of human disease but are used due to the challenges of working in humans. We've created a human ‘immune system in a di…
Heads up I went to email you a congratulatory email at hello@parallel.bio but my email was rejected. Might want to double check your google groups settings.
Launch YC S21: Meet the Batch, Thread #6
91–100 of 120 posts
Re: Launch YC S21: Meet the Batch, Thread #6
#92Hey everyone! We’re Juliana and Robert, co-founders of Parallel Bio. We're improving drug discovery by replacing animal models, in the hope of making cures for humans, not mice. The biggest reason why 92% of new drugs fail is that drugs are currently discovered in mice, which are not realistic models of human disease but are used due to the challenges of working in humans. We've created a human ‘immune system in a di…
Amazing and very cool! A couple of questions, if you can share at this time, since this resonates with my interests. - Which patient/donor cell type are these immune organoids derived from? - Are the organoids made with induced pluripotent stem cell technology? - What is part of the workup post treatment, e.g. histology, NGS? If NGS, what kind (WGS, WES, RNASeq) and technologies (Illumina, PacBio, ONT)? - Are you loo…
- They're derived from secondary lymphoid tissue. We're trying to biobank as broadly as we can to capture sex, age, race, HLA, genetics, and other characteristics in a wide net.
- These are not iPSC-derived organoids.
- This depends on the readout but workup post treatment so far has included histology, immunofluorescence, serology (ELISA, SPR, etc.), CyTOF and other flow, broad RNA-seq, bulk and single cell repertoire sequencing for B and T cells, and MSD/Luminex.
- We haven't looked for mutations from drug and vaccine treatment. We'd love to know more about what you're thinking there.
Re: Launch YC S21: Meet the Batch, Thread #6
#93We are the founders of Kodex ( https://www.kodex.us ). Kodex makes it easy for companies to process and respond to subpoenas from governments around the world. Government agencies subpoena user data from thousands of companies around the world, and companies largely rely on email, fax, and spreadsheets to manage them. At a previous job, we would frequently see companies struggle to comply with legal orders, because t…
Congrats on the launch. What's the hardest thing you have found getting Kodex to this point? How many government bodies are you connected to? Can you use your platform even if they do not use it? Do you use a subscription pricing model?
We have about 60 agencies verified with us so far. What's interesting about this problem is that the company dictates how government agencies contact them. As a result, the moment our customers adopt Kodex, they automatically pull in any government agency that wants to contact them. We have new government agents signing up everyday to send our customers requests.
We do use an annual subscription pricing model.
Happy to connect offline!
Re: Launch YC S21: Meet the Batch, Thread #6
#94We are the founders of Kodex ( https://www.kodex.us ). Kodex makes it easy for companies to process and respond to subpoenas from governments around the world. Government agencies subpoena user data from thousands of companies around the world, and companies largely rely on email, fax, and spreadsheets to manage them. At a previous job, we would frequently see companies struggle to comply with legal orders, because t…
Re: Launch YC S21: Meet the Batch, Thread #6
#95Hey HN, I’m Etai, together with Andrew a co-founder of Secoda ( https://www.secoda.co ). Secoda is a collaborative workspace for data teams that makes it easy to share metadata, queries, charts and documentation with any employee. Companies store a growing amount of knowledge in BI tools, data warehouses, data pipelines, queries and documentation. Because these tools are not connected, it has become more difficult to…
Re: Launch YC S21: Meet the Batch, Thread #6
#96Re: Launch YC S21: Meet the Batch, Thread #6
#97We are the founders of Kodex ( https://www.kodex.us ). Kodex makes it easy for companies to process and respond to subpoenas from governments around the world. Government agencies subpoena user data from thousands of companies around the world, and companies largely rely on email, fax, and spreadsheets to manage them. At a previous job, we would frequently see companies struggle to comply with legal orders, because t…
Re: Launch YC S21: Meet the Batch, Thread #6
#98We are the founders of Kodex ( https://www.kodex.us ). Kodex makes it easy for companies to process and respond to subpoenas from governments around the world. Government agencies subpoena user data from thousands of companies around the world, and companies largely rely on email, fax, and spreadsheets to manage them. At a previous job, we would frequently see companies struggle to comply with legal orders, because t…
I think this is really great. Do you have a public transparency report feature on the roadmap?
Love to know your thoughts!
Re: Launch YC S21: Meet the Batch, Thread #6
#99We are the founders of Kodex ( https://www.kodex.us ). Kodex makes it easy for companies to process and respond to subpoenas from governments around the world. Government agencies subpoena user data from thousands of companies around the world, and companies largely rely on email, fax, and spreadsheets to manage them. At a previous job, we would frequently see companies struggle to comply with legal orders, because t…
How big is the market? It seems people who really need this and see it frequently have the resources to build their own and its otherwise rare enough to not be worth a whole product.
I think that is the most common misconception with this problem, and that is why it has gone so long without a solution. You are correct in that the biggest players (i.e. big tech) are the ones who have the resources to solve their own problems. However, this problem spreads much further and wider than just big tech. There are thousands of companies in the US alone that get these requests (from ISPs, banks, insurance, fintechs, crypto, tech, etc.). "Big tech" typically gets all the focus because of the volume they get (FB gets 300k+ per year). What goes unnoticed is that even at 100+, or 1000+ per year, these requests are very overwhelming for companies to manage. These are also the companies that don't have the internal resources to fix their pain like FB and Google.
Re: Launch YC S21: Meet the Batch, Thread #6
#100Earlier quoted context omitted.
How big is the market? It seems people who really need this and see it frequently have the resources to build their own and its otherwise rare enough to not be worth a whole product.
I'm glad you brought that up! I think that is the most common misconception with this problem, and that is why it has gone so long without a solution. You are correct in that the biggest players (i.e. big tech) are the ones who have the resources to solve their own problems. However, this problem spreads much further and wider than just big tech. There are thousands of companies in the US alone that get these request…